DNAmito Email Format

Hospitals and Health CareCalifornia, United States2-10 Employees

DNAmito is a small health care company based in Palo Alto, California, focused on personalizing cancer treatment planning through genomics. PRODECIS is a clinical-grade decision support system for the personalized treatment of cancer. The AI-based predictive models consider toxicity, tumor control, quality of life and cost-effectiveness, and integrate biological, genetic, clinical and imaging data to compare treatment options. By presenting tailored options, PRODECIS helps radiation oncologists select the most appropriate treatment path for each patient.
MITOTx is a next-generation predictive DNA sequencing product under development that uses saliva-based SNP and mitochondrial DNA testing to assess the risk of radiation-induced toxicity. This genetic test addresses a gap in current radiation therapy practice by indicating complication risk and guiding patients to radiation regimens that minimize exposure to healthy tissue, while also signaling the possibility of higher doses when tolerated to improve treatment effectiveness.

Sign up for free to view info

Company overview Employee directory